Phosmet

Phosmet

SCHEMBL1663406

COP(=S)(OC)SCN1C(=O)c2ccccc2C1=O.COP(=S)(OC)SCN1C(=O)c2ccccc2C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 1.00
MAPT P10636 3/20 1.00
HPGD P15428 2/20 1.00
ALOX15 P16050 2/20 1.00
PLIN1 O60240 1/20 1.00
PLIN5 Q00G26 1/20 1.00
ABHD5 Q8WTS1 1/20 1.00
MAPK1 P28482 2/20 0.49
HSD17B10 Q99714 2/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
CYP3A4 P08684 1/20 0.49
TSHR P16473 1/20 0.49
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPC1 O15118 2/20 0.42
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
POLB P06746 1/20 0.42
CASP3 P42574 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosmet SCHEMBL29350557 1.00 ALDH1A1 (1.00) ALDH1A1MAPTHPGDALOX15PLIN1
Phosmet SCHEMBL3620 1.00 ALDH1A1 (1.00) ALDH1A1MAPTHPGDALOX15PLIN1
Phosmet SCHEMBL7246728 0.92 ALDH1A1 (0.84) ALDH1A1MAPTHPGDALOX15PLIN1
SCHEMBL13596981 0.90 ALDH1A1 (0.81) ALDH1A1MAPTHPGDALOX15PLIN1
Phosmet SCHEMBL15561615 0.88 ALDH1A1 (0.78) ALDH1A1MAPTHPGDALOX15PLIN1
SCHEMBL11554380 0.84 HPGD (0.73) ALDH1A1MAPTHPGDALOX15PLIN1
SCHEMBL29378607 0.82 ALDH1A1 (0.69) ALDH1A1MAPTHPGDALOX15PLIN1
SCHEMBL5933920 0.82 ALDH1A1 (0.69) ALDH1A1MAPTHPGDALOX15PLIN1
Phosmet SCHEMBL1070968 0.80 ALDH1A1 (0.63) ALDH1A1MAPTHPGDALOX15PLIN1
Phosmet SCHEMBL428639 0.80 ALDH1A1 (0.63) ALDH1A1MAPTHPGDALOX15PLIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2491054-A2 SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST Cadila Healthcare Limited (IN) 2012-08-29 EP claimed
WO-2011048614-A2 SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST CADILA HEALTHCARE LIMITED (IN) 2011-04-28 WO claimed
US-6528079-B2 For treatment of woody plants; employed in a hollow preformed in the woody plant BAYER AKTIENGESELLSCHAFT (DE) 2003-03-04 US disclosed
US-20020061323-A1 SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2002-05-23 US disclosed
EP-0564945-B1 A method of controlling harmful insects BAYER AGROCHEM KK (JP) 2001-01-24 EP disclosed
US-6063393-A RODS OR PINS TO BE PRESSED INTO PLANTS NIHON BAYER AGROCHEM K.K. (JP) 2000-05-16 US disclosed
EP-0564945-A1 A method of controlling harmful insects NIHON BAYER AGROCHEM K.K. (JP) 1993-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061323-A1 SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES AGL, CHMP4B, GUSB ALDH1A1 729/4885MAPT 1236/4885HPGD 1027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.